Home / Knowledge Centre /
Case study

Supporting small domestic trials cost effectively

Simplify™ deployed for 70% less than fully customised IRT platform


For years, a major, multi-national pharmaceutical company has relied on a highly customised IRT platform to manage the majority of its large, global studies. Almac’s full-featured IXRS®3, as customised for the company, is replete with a vast number of enhancements and data integration capabilities. Yet, the system, no matter how advantageous in most circumstances, was going to be excessive for the needs of a program of domestic trials in Japan. Could Almac offer its long-standing partner a solution scaled to fit the trials’ budget and less complex protocols?

Download the case study now.

View Resource

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies